ATE174515T1 - Verwendung eines cdw52-spezifischen antikörpers zur behandlung von durch t-zellen vermittelten gelenkentzündungen - Google Patents

Verwendung eines cdw52-spezifischen antikörpers zur behandlung von durch t-zellen vermittelten gelenkentzündungen

Info

Publication number
ATE174515T1
ATE174515T1 AT93908763T AT93908763T ATE174515T1 AT E174515 T1 ATE174515 T1 AT E174515T1 AT 93908763 T AT93908763 T AT 93908763T AT 93908763 T AT93908763 T AT 93908763T AT E174515 T1 ATE174515 T1 AT E174515T1
Authority
AT
Austria
Prior art keywords
treatment
cdw52
cell
specific antibody
antibody
Prior art date
Application number
AT93908763T
Other languages
English (en)
Inventor
Herman Waldmann
Geoffrey Hale
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215749A external-priority patent/GB9215749D0/en
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of ATE174515T1 publication Critical patent/ATE174515T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93908763T 1991-10-15 1992-10-14 Verwendung eines cdw52-spezifischen antikörpers zur behandlung von durch t-zellen vermittelten gelenkentzündungen ATE174515T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77559891A 1991-10-15 1991-10-15
GB929215749A GB9215749D0 (en) 1992-07-24 1992-07-24 Medicaments

Publications (1)

Publication Number Publication Date
ATE174515T1 true ATE174515T1 (de) 1999-01-15

Family

ID=26301317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908763T ATE174515T1 (de) 1991-10-15 1992-10-14 Verwendung eines cdw52-spezifischen antikörpers zur behandlung von durch t-zellen vermittelten gelenkentzündungen

Country Status (12)

Country Link
EP (1) EP0610447B1 (de)
JP (1) JP3535155B2 (de)
KR (1) KR100264218B1 (de)
AT (1) ATE174515T1 (de)
AU (1) AU671807B2 (de)
CA (1) CA2120911A1 (de)
DE (1) DE69227918T2 (de)
DK (1) DK0610447T3 (de)
ES (1) ES2125977T3 (de)
IL (1) IL103418A (de)
MY (1) MY115415A (de)
WO (1) WO1993007899A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
GB9603507D0 (en) * 1996-02-20 1996-04-17 Isis Innovation Antibody variants
GB2380127A (en) 2001-09-26 2003-04-02 Isis Innovation Treatment of chronic joint inflammation
BR112014029417B1 (pt) * 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121823B2 (ja) * 1988-02-12 2001-01-09 ビーティージー・インターナショナル・リミテッド 抗体におけるまたは抗体に関する改良
DE69028713T3 (de) * 1989-12-27 2004-05-13 Centocor, Inc. Schimäre immunoglobuline für cd4-rezeptoren
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin

Also Published As

Publication number Publication date
KR100264218B1 (ko) 2000-08-16
JPH07500330A (ja) 1995-01-12
AU671807B2 (en) 1996-09-12
IL103418A (en) 1997-11-20
DE69227918T2 (de) 1999-05-12
CA2120911A1 (en) 1993-04-29
DK0610447T3 (da) 1999-08-23
DE69227918D1 (de) 1999-01-28
JP3535155B2 (ja) 2004-06-07
MY115415A (en) 2003-06-30
EP0610447B1 (de) 1998-12-16
AU2698592A (en) 1993-05-21
IL103418A0 (en) 1993-03-15
ES2125977T3 (es) 1999-03-16
EP0610447A1 (de) 1994-08-17
WO1993007899A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
DE69228556D1 (de) CDw52-SPEZIFISCHER ANTIKÖRPER ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
GB2294267A (en) Antibody fragments in therapy
ATE208820T1 (de) Humanisierte antikoerper
DE69329621D1 (de) MONOKLONALE ANTIKöRPER GEGEN DEFINIIERTE REGIONEN DES T-ZELL-ANTIGENREZEPTORS
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE10199051I2 (de) Modifizierte Antik¦rper.
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
DE69632465D1 (de) Cdr-transplantierte antikörper gegen "tissue factor" und verfahren zur deren verwendung
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
ATE174515T1 (de) Verwendung eines cdw52-spezifischen antikörpers zur behandlung von durch t-zellen vermittelten gelenkentzündungen
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
FR2677653B1 (de)
AU584690B2 (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
WO2024039672A3 (en) Antibodies against msln and methods of use thereof
FI942392L (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DE59207362D1 (de) Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
ATE184315T1 (de) Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt
DE69329109D1 (de) Nachweisverfahren für adrenale autoantikörper
HUP9903273A3 (en) Anti-human mp52 monoclonal antibody
DK182188A (da) Humant tumorassocieret antigen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification